T. Mitsui et al., Vesicourethral function in diabetic patients: Association of abnormal nerve conduction velocity with vesicourethral dysfunction, NEUROUROL U, 18(6), 1999, pp. 639-645
This study was undertaken to examine diabetic vesicourethral dysfunction in
association with nerve conduction velocity. Uroflowmetry, water cystometry
, International Prostate Symptom Score (IPSS), and nerve conduction velocit
y were analyzed in 29 diabetic patients (21 men and eight women; a mean age
, 58.0 years). Nerve conduction velocity was measured for sensory nerve con
duction velocity (SCV) of the sural nerve and motor nerve conduction veloci
ty (MCV) of the peroneal nerve. Normal voiding was defined as continuous fl
ow at the normal flow rate and residual urine <50 mt. Results of uroflowmet
ry and cystometry were compared with those of nerve conduction velocity. El
even of 29 patients (38%) had voiding dysfunction. A vesical denervation su
persensitivity test was negative in all patients. The mean IPSS was not sig
nificant different between patients with or without voiding dysfunction. In
cidence of bladder volume at first desire to void >300 mt and maximum bladd
er capacity >500 mt were significantly higher in patients with abnormal SCV
than those with normal SCV (P < 0.03 and 0.001, respectively). Eleven of 1
6 patients with abnormal MCV showed voiding dysfunction, whereas all patien
ts with normal MCV showed normal voiding (P < 0.001). These results suggest
that lower urinary tract symptoms alone cannot predict diabetic vesicouret
hral dysfunction and that diabetic vesicourethral dysfunction is highly cor
related with abnormal nerve conduction velocity. (C) 1999 Wiley-Liss, Inc.